Quantity | = | Concentration | x | Volume | x | Molecular Weight |
---|---|---|---|---|---|---|
= | x | x |
1) Click the Molarity Calculation Cart® button.
2) Specify the Concentration and Volume of your desired Molarity.
3) Click Calculate.
4) Your desired Quantity will be calculated and will be put under Quantity: (only for mg)
5) Click Add to Cart and then Proceed to checkout to complete the order. You will receive the quantity as you ordered as solvent-free form.
Alert: If you want to make a solution with a solvent (such DMSO), please add instructions in the notes section (such as 10 nM/1 mL in DMSO) and we will pack and deliver the product as a solution (such as 10 nM solution in 1 mL DMSO). If the product cannot be dissolved in DMSO or you would like to specify your own preferred solvent, please add detailed instructions in the notes section. All solutions must be shipped with an ice bag, costing an additional fee of $20 for S&H.
AOB5618
CAS Number 79094-20-5
Chemical Name: 4-[2-[[(4-
Warning: Last items in stock!
Availability date:
Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
---|---|---|---|
1 | 100 | $9.45 | Total: $945.00 |
1 | 50 | $10.92 | Total: $546.00 |
1 | 25 | $12.81 | Total: $320.25 |
1 | 10 | $15.12 | Total: $151.20 |
1 | 5 | $17.85 | Total: $89.25 |
Molecular Formula | C16H16ClNO4S |
Molecular Weight | 353.82 |
CAS Numbers | 79094-20-5 |
Storage Condition | 0°C (short term), -20°C (long term), desiccated |
Solubility | 22 mg/mL in DMSO |
Purity | 98% by HPLC |
Synonym | BM 13505; SKF 96148 |
IUPAC/Chemical Name | 4-[2-[[(4-chlorophenyl)sulfonyl]amino]ethyl]-benzeneacetic acid |
InChl Key | IULOBWFWYDMECP-UHFFFAOYSA-N |
InChl Code | InChI=1S/C16H16ClNO4S/c17-14-5-7-15(8-6-14)23(21,22)18-10-9-12-1-3-13(4-2-12)11-16(19)20/h1-8,18H,9-11H2,(H,19,20) |
SMILES Code | O=S(NCCC1=CC=C(CC(O)=O)C=C1)(C2=CC=C(Cl)C=C2)=O |
References | 1) Bertolino, F., Valentin, J.P., Maffre, M., et al. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo. Br. J. Pharmacol. 115, 210-216 (1995). 2) Bitterman, H., Yanagisawa, A., and Lefer, A.M. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock. Circ. Shock 20(1), 1-11 (1986). |
Selective thromboxane A2 receptor antagonist